🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Arivarasan Karunamurthy

University of Pittsburgh

ORCID: 0000-0002-5739-4923

Also affiliated with University of Pittsburgh Medical Center

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 4%percentile
0.802Author DataRank

Indexed papers

2in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Human BioMolecular Atlas Program (HuBMAP): 3D Human Reference Atlas construction and usage

Nature Methods(2025)10.1038/s41592-024-02563-5
Top 25%
0.802DataRank
Top 25%33 citations

Philip D. Blood, Jonathan C. Silverstein, Matthew Ruffalo, Rahul Satija, Sarah A. Teichmann +95 more

Papers

Driven by 15 papers — median percentile 37. Top paper: “Neoadjuvant vidutolimod and nivolumab in high-risk resectable melanoma: A prospective phase II trial”.

Neoadjuvant vidutolimod and nivolumab in high-risk resectable melanoma: A prospective phase II trial

Cancer Cell(2024)10.1016/j.ccell.2024.10.007
N/A
1.3DataRank · unranked
59 citations

Robert M. Morrison, Amiran Dzutsev, Arivarasan Karunamurthy, Joë-Marc Chauvin, F. Amatore +48 more

Human BioMolecular Atlas Program (HuBMAP): 3D Human Reference Atlas construction and usage

Nature Methods(2025)10.1038/s41592-024-02563-5
Top 25%
0.802DataRank
Top 25%33 citations

Philip D. Blood, Jonathan C. Silverstein, Matthew Ruffalo, Rahul Satija, Sarah A. Teichmann +95 more

Enhanced immune activation within the tumor microenvironment and circulation of female high-risk melanoma patients and improved survival with adjuvant CTLA4 blockade compared to males

Journal of Translational Medicine(2022)10.1186/s12967-022-03450-3
N/A
0.614DataRank · unranked
12 citations

Sandra J. Lee, Aik Choon Tan, Issam M. El Naqa, F. Stephen Hodi, Lisa H. Butterfield +10 more

3D reconstruction of skin and spatial mapping of immune cell density, vascular distance and effects of sun exposure and aging

Communications Biology(2023)10.1038/s42003-023-04991-z
N/A
0.483DataRank · unranked
24 citations

Yingnan Ju, Elizabeth McDonough, Jonhan Ho, Arivarasan Karunamurthy, Chrystal Chadwick +12 more

Expression of lymphoid structure-associated cytokine/chemokine gene transcripts in tumor and protein in serum are prognostic of melanoma patient outcomes

Frontiers in Immunology(2023)10.3389/fimmu.2023.1171978
N/A
0.360DataRank · unranked
10 citations

Hassan Abushukair, Aofei Li, Andrew Knight, Ayah Nedal Al Bzour, Ian MacFawn +16 more

605 Neoadjuvant vidutolimod (vidu) and nivolumab (nivo) results in MPR and immune activation in high-risk resectable melanoma (MEL): final phase II clinical trial results

Regular and Young Investigator Award Abstracts(2022)10.1136/jitc-2022-sitc2022.0605
N/A
0.272DataRank · unranked
4 citations

Joë-Marc Chauvin, Robert Morrison, Yulong Bai, Jie Sun, Hong Wang +22 more

Lead-in therapy targeting PD1 and/or LAG3 imposes distinct immune phenotypes in first-line treatment of metastatic melanoma

medRxiv(2025)10.1101/2025.11.04.25339499
N/A
0.165DataRank · unranked
2 citations

Anthony R. Cillo, Shuaichao Wang, Arivarasan Karunamurthy, Ryan Massa, Anjali Rohatgi +16 more

Improved prognosis and evidence of enhanced immunogenicity in tumor and circulation of high-risk melanoma patients with unknown primary

Journal for ImmunoTherapy of Cancer(2022)10.1136/jitc-2021-004310
N/A
0DataRank · unranked
19 citations

Sandra J. Lee, Aik Choon Tan, Issam M. El Naqa, F. Stephen Hodi, Lisa H. Butterfield +9 more

Anatomical Structures, Cell Types, plus Biomarkers (ASCT+B) table for Skin, v1.6

The Human BioMolecular Atlas Program (HuBMAP) Reference Repository(2025)10.48539/hbm739.ndcd.287
Top 100%
0DataRank
Top 100%0 citations

Jonhan Ho, Joel Sunshine, Arivarasan Karunamurthy, Fiona Ginty

Neoadjuvant Vidutolimod and Nivolumab in High-Risk Resectable Melanoma

Research Square(2022)10.21203/rs.3.rs-2235839/v1
N/A
0DataRank · unranked
1 citations

Arivarasan Karunamurthy, Joë-Marc Chauvin, Robert M. Morrison, Yulong Bai, Jie Sun +40 more

Blockade of LAG-3 and PD-1 leads to co-expression of cytotoxic and exhaustion gene modules in CD8+ T cells to promote antitumor immunity

Cell(2024)10.1016/j.cell.2024.06.036
N/A
0DataRank · unranked
157 citations

Carly Cardello, Feng Shan, Lilit Karapetyan, Sheryl Kunning, Cindy Sander +9 more

Evaluation and Surgical Management of Pediatric Cutaneous Melanoma and Atypical Spitz and Non-Spitz Melanocytic Tumors (Melanocytomas): A Report From Children's Oncology Group

Journal of Clinical Oncology(2024)10.1200/jco.24.01154
N/A
0DataRank · unranked
21 citations

Raymond L. Barnhill, David E. Elder, Susan M. Swetter, Víctor G. Prieto, Jennifer S. Ko +28 more

FUSION: a web-based application for in-depth exploration of multi-omics data with brightfield histology

Nature Communications(2025)10.1038/s41467-025-63050-9
N/A
0DataRank · unranked
1 citations

Ricardo Melo Ferreira, Nicholas Lucarelli, Suhas Katari Chaluva Kumar, Anindya S. Paul, David Manthey +21 more

Exploring endothelial cell environments across organs in spatially resolved omics data

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.09.23.678129
N/A
0DataRank · unranked
3 citations

Jodie Jepson, Roy Chen, Elizabeth Maier, Bruce W. Herr, Aleix Puig-Barbe +24 more

1340 Lead-in therapy targeting PD1 and/or LAG3 distinguishes differential impacts upon the immune response in first-line treatment of metastatic melanoma

(2025)10.1136/jitc-2025-sitc2025.1340
N/A
0DataRank · unranked
0 citations

Anthony R. Cillo, Shuaichao Wang, Arivarasan Karunamurthy, Ryan Massa, Anjali Rohatgi +15 more